Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
Nature Genetics2002Vol. 31(1), pp. 55–59
Citations Over TimeTop 1% of 2002 papers
Rogier A. Oldenburg, Hanne Meijers‐Heijboer, Monique van Veghel‐Plandsoen, Anja de Snoo, Ans van den Ouweland, Ellen Crepin, Marijke Wasielewski, Hanne Meijers‐Heijboer, Fons Elstrodt, Jan G.M. Klijn, Antoinette Hollestelle, Mieke Schutte, M.P.W.A. Houben, Cornelia M. van Duijn, Carina C. M. Bartels, Carel Meijers, Deborah J. Thompson, Lesley McGuffog, Douglas F. Easton, Rita Barfoot, Michael R. Stratton, Rosalind A. Eeles, Nazneen Rahman, Sheila Seal, Nayanta Sodha, Jon Mangion, Richard S. Houlston, Jenny Chang‐Claude, Diana Eccles, D. Gareth Evans, Victoria Murday, Catherine Phelan, Steven A. Narod, T. Peretz, Julian Peto, Julian Peto, Barbara L. Weber, Hong Xiang Zhang, Katherine L. Nathanson, David E. Goldgar, Csilla I. Szabo, Peter Devilee, Michael R. Stratton, P. Andrew Futreal
Related Papers
- → Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network(2021)34 cited
- → Moderate-Penetrance Predisposition to Breast Cancer(2018)1 cited
- → Abstract 1291: High and moderate penetrance germline mutations in a number of genes are responsible for a small proportion of familial breast cancer risk in BRCAx families(2014)
- → Abstract ES2-3: Managing increased breast cancer risk based on high and moderate penetrance gene mutations(2018)
- → Penetrance of breast cancer genes from the eMERGE III Network(2021)